|
1
|
Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
|
Science
|
1984
|
3.47
|
|
2
|
The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.
|
J Clin Invest
|
1967
|
2.53
|
|
3
|
Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.
|
N Engl J Med
|
1992
|
1.45
|
|
4
|
Effects of secretin on insulin and glucagon in portal and peripheral blood in man.
|
Lancet
|
1966
|
1.44
|
|
5
|
Diabetes mellitus in aircrew--type I diabetes in a pilot.
|
Aviat Space Environ Med
|
1995
|
1.40
|
|
6
|
Immunotherapy in pre-type 1 diabetes mellitus.
|
Diabetologia
|
1990
|
1.39
|
|
7
|
Identification and actions of gastric inhibitory polypeptide.
|
Recent Prog Horm Res
|
1975
|
1.38
|
|
8
|
Effect of secretin on insulin secretion.
|
Lancet
|
1966
|
1.35
|
|
9
|
Stimulation of release of insulin by an extract of intestinal mucosa.
|
Diabetes
|
1966
|
1.13
|
|
10
|
Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy.
|
Br J Ophthalmol
|
1982
|
1.11
|
|
11
|
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up.
|
Diabetologia
|
2010
|
1.10
|
|
12
|
Regulation of insulin secretion by the intestinal hormone, secretin: studies in man via transumbilical portal vein catheterization.
|
Surgery
|
1968
|
0.96
|
|
13
|
Subcutaneous glucagon-like peptide I combined with insulin normalizes postcibal glycemic excursions in IDDM.
|
Diabetes Care
|
1997
|
0.94
|
|
14
|
Alimentary factors in the endocrine response to administration of arginine in man.
|
Lancet
|
1968
|
0.92
|
|
15
|
Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
|
Diabetes
|
1977
|
0.92
|
|
16
|
Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects.
|
Diabetologia
|
1991
|
0.89
|
|
17
|
Regulation of pancreatic endocrine function by gastrointestinal hormones.
|
Proc R Soc Med
|
1968
|
0.85
|
|
18
|
Glucose turnover and insulin sensitivity in rats with pancreatic islet transplants.
|
Diabetes
|
1998
|
0.82
|
|
19
|
Effect of clonidine on growth hormone and glucagon secretion.
|
Horm Metab Res
|
1981
|
0.81
|
|
20
|
Regulation of the secretions of the pancreas.
|
Annu Rev Med
|
1970
|
0.81
|
|
21
|
Transplantation of encapsulated allogeneic islets into diabetic BB/W rats. Effects of immunosuppression.
|
Transplantation
|
1991
|
0.81
|
|
22
|
Effects of the gastric inhibitory polypeptide present in impure pancreozymin-cholecystokinin on plasma insulin and glucagon in the rat.
|
Endocrinology
|
1974
|
0.80
|
|
23
|
Insulinotropic action of secretin.
|
Br Med J
|
1967
|
0.80
|
|
24
|
Reduction by morphine of human postprandial insulin release is secondary to inhibition of gastrointestinal motility.
|
Diabetes
|
1986
|
0.79
|
|
25
|
Canine, human, and rat plasma insulin responses to galanin administration: species response differences.
|
Am J Physiol
|
1994
|
0.79
|
|
26
|
Immunosuppressive drugs in diabetes.
|
Lancet
|
1986
|
0.78
|
|
27
|
Galanin: a selective inhibitor of insulin secretion?
|
Pancreas
|
1988
|
0.78
|
|
28
|
Effects of secretin on insulin secretion and glucose tolerance.
|
Can J Physiol Pharmacol
|
1975
|
0.77
|
|
29
|
Determination of molecular associations of some hydrophobic and hydrophilic bile acids by infrared and Raman spectroscopy.
|
Eur Biophys J
|
1997
|
0.76
|
|
30
|
Proteins and insulin release.
|
Br Med J
|
1970
|
0.75
|
|
31
|
Immunosuppression in IDDM. Rationale, risks, benefits, and strategies.
|
Diabetes Care
|
1990
|
0.75
|
|
32
|
Insulin therapy: progress and prospects.
|
Hosp Pract (Off Ed)
|
1983
|
0.75
|
|
33
|
[Late consequences of the war-time disruption of the family in Jewish students].
|
Rev Neuropsychiatr Infant
|
1965
|
0.75
|
|
34
|
Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts.
|
Diabetes
|
1997
|
0.75
|
|
35
|
[Efficacy of continuous administration of insulin by subcutaneous route in the treatment of insulin-dependent diabetes mellitus].
|
Journ Annu Diabetol Hotel Dieu
|
1982
|
0.75
|
|
36
|
The entero-insular axis and the metabolic effects of gastro-enteropancreatic polypeptides.
|
Clin Gastroenterol
|
1980
|
0.75
|
|
37
|
Double resolvance obtenue avec un spectromètre de type SISAM.
|
Appl Opt
|
1971
|
0.75
|
|
38
|
Rats with portal-caval vein transposition show hyperinsulinemia and insulin resistance.
|
Metabolism
|
1996
|
0.75
|
|
39
|
Diabetes-related autoantibodies and the selection of subjects for trials of therapies to preserve pancreatic beta-cell function in recent-onset type 1 diabetes.
|
Diabetes Care
|
2000
|
0.75
|
|
40
|
[Not Available].
|
Bull Soc Fr Hist Hop
|
1980
|
0.75
|
|
41
|
Stein-Leventhal Syndrome.
|
Proc R Soc Med
|
1963
|
0.75
|
|
42
|
Hepatic factors in glucose disposal in dogs with portacaval shunts.
|
Surg Forum
|
1970
|
0.75
|
|
43
|
The effect of bromocriptine and cyclosporine on spontaneous diabetes in BB rats.
|
Transplant Proc
|
1988
|
0.75
|
|
44
|
The role of pancreozymin in insulin release and glucose disposal in the dog.
|
Surg Forum
|
1972
|
0.75
|
|
45
|
Rat and porcine galanin are equipotent in inhibiting insulin responses to glucose in the anesthetized rat.
|
Pancreas
|
1990
|
0.75
|
|
46
|
Suppression of insulin receptor binding by prolonged enteral or parenteral nutrient infusion in the rat: role of gastric inhibitory polypeptide.
|
Can J Physiol Pharmacol
|
1989
|
0.75
|